Cowen Inc. (NASDAQ:COWN) (“Cowen” or the “Company) today announced that its Board of Directors has approved an increase in the Company’s existing share repurchase program (the “Share Repurchase Program”). With this increase, the total amount now available for repurchase under the current plan is $50 million.
Bellicum Pharma Shares Quiet; Traders Circulate European Patent Register For Co.’s ‘METHODS FOR INDUCING PARTIAL APOPTOSIS USING CASPASE POLYPEPTIDES’
https://register.epo.org/application?number=EP19173088&tab=main
